Strategic Analysis of World HIV Therapeutics Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This research service analyzes the changing dynamics within the global HIV therapeutics market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, analysis of growth opportuniters, and individual product forecasts and analysis. The market is segmented by product class - NRTIs, NNRTIs, PIs, and EIs - while also examining revenue potential in the United States, Europe, Asia, and Africa. This research service discusses the current and future market landscape, critically evaluates each major product, and highlights the window of opportunities in this limitless market.

Table of Contents

Strategic Analysis of World HIV Therapeutics Markets, Strategic Analysis of World HIV Therapeutics MarketsOverviewIntroductionDisclaimerCertificationResearch Scope and MethodologyMarket Segmentation by Geographical RegionMarket Segmentation by Product ClassKey DefinitionsDemand AnalysisPrevalence by Geographical RegionTotal HIV/AIDS Patient Population ForecastsPatient Population AnalysisState of the Epidemic QuoteMarket DynamicsIndustry ChallengesMarket and Technology TrendsExecutive Quote2003 HIV Product RevenuesTotal Market Revenue ForecastsTotal Market Revenue AnalysisRevenue Forecasts by Product ClassHIV Therapeutics Market by Product ClassMarket Share Analysis by Product ClassProduct Life Cycle AnalysisHIV Therapeutics Market by CompanyMarket Share Analysis by CompanyHIV Therapeutics Market by Geographical RegionRevenue Forecasts by Geographical RegionGrowth Analysis by Geographical RegionRevenue Analysis by Geographical RegionNRTI Market Forecasts and AnalysisNRTI Revenue ForecastsNRTI Revenue AnalysisNRTI Market by CompanyNRTI Market Share AnalysisViread Revenue ForecastsViread Revenue AnalysisNRTI Pipeline AnalysisNNRTI Market Forecasts and AnalysisNNRTI Revenue ForecastsNNRTI Revenue AnalysisNNRTI Market by CompanyNNRTI Market Share AnalysisSustiva Revenue ForecastsSustiva Revenue AnalysisNNRTI Pipeline AnalysisPI Market Forecasts and AnalysisPI Revenue ForecastsPI Revenue AnalysisExecutive QuotePI Market by CompanyPI Market Share AnalysisKaletra Revenue ForecastsKaletra Revenue AnalysisReyataz and Lexiva: Product AnalysisPI Pipeline AnalysisEI Market Forecasts and AnalysisEI Revenue ForecastsEI Revenue AnalysisFuzeon Revenue ForecastsFuzeon Revenue AnalysisEI Pipeline AnalysisExecutive QuoteMarket EvolutionTreatment PrioritiesPotential ThreatsAchieving Sustained Value GrowthGrowth OpportunitiesWhat Can Be Expected in the Future?Notable Products In DevelopmentExecutive QuoteCompetitive LandscapeGlaxoSmithKlineBristol-Myers SquibbAbbott LaboratoriesGilead SciencesPfizerBoehringer IngelheimMerckRocheMacroeconomic Analysis IMacroeconomic Analysis IIComponents of MacroenvironmentFrost & Sullivan AwardsIntroductionCompany of the Year AwardProduct Innovation AwardCustomer Value AwardMarket Leadership AwardFrost & SullivanHealthcare TeamOur CapabilitiesKey AdvantagesOur Consulting ClientsGrowth ConsultingGrowth Consulting ProcessGrowth Consulting DeliverablesGrowth Partnership ServiceGrowth Partnership Service Platform




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.